FIELD: biotechnologies.
SUBSTANCE: invention is related to biotechnology and represents substantially pure peptide for modulation of immune system, which is characterised with aminoacid sequence VAPEEHPTLLTEAPLNPK, and also pharmaceutical composition, which includes specified peptide.
EFFECT: possibility to modulate immune activity selected from the group that consists of suppression of T-lymphocytes transformation, suppression of activity of NK-cells and suppression of antibodies production.
7 cl, 5 dwg, 15 tbl, 12 ex
Authors
Dates
2009-12-27—Published
2005-04-25—Filed